Plain-English translation of NCT06919029 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing the MiniMed 780G, an advanced insulin pump system that works automatically to help manage type 1 diabetes in children and teenagers who have just been diagnosed. The pump uses a glucose sensor to check blood sugar levels throughout the day and automatically adjusts insulin delivery. Researchers want to see if starting this treatment right after diagnosis helps young people achieve better blood sugar control compared to those using traditional insulin injections.
When type 1 diabetes is newly diagnosed, it's a critical time to establish good blood sugar control to prevent long-term health problems. This study aims to find out whether starting this automated treatment early can help young patients achieve better results and improve their quality of life from the very beginning.
You likely qualify if…
You likely don't qualify if…
You would start using the MiniMed 780G pump system right after your diabetes diagnosis, along with the glucose sensor that measures your blood sugar throughout the day. The study lasts 6 months total: the first 3 months are the main study period, followed by a 3-month extension. During this time, you'll wear the pump and sensor, follow the study instructions, and download your data regularly using special software so the research team can track how well your blood sugar is controlled.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Greece